CIK 0000318306
- Non-accelerated filer
- Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 830221517
- Phone
- +1 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $34,349
- in 1 filing
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$262,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-12-14 | Jeffrey B Davis COO | Grant or award · Stock option (right to buy) | +20,000 | 20,000 | ||
| 2017-12-14 | Jeffrey B Davis COO | Grant or award · Stock option (right to buy) | +60,000 | 60,000 | ||
| 2016-12-13 | Jeffrey B Davis Chief Operating Officer | Grant or award · Stock option (right to buy) | +37,500 | 37,500 | ||
| 2016-12-13 | Jeffrey B Davis Chief Operating Officer | Grant or award · Stock option (right to buy) | +112,500 | 150,000 | ||
| 2016-02-11 | Jeffrey B Davis Chief Operating Officer | Grant or award · Stock option (right to buy) | +37,500 | 37,500 | ||
| 2016-02-11 | Jeffrey B Davis Chief Operating Officer | Grant or award · Stock option (right to buy) | +112,500 | 150,000 | ||
| 2015-05-11 | Jeffrey B Davis Cheif Operating Officer | Grant or award | +300,000 | 300,000 | ||
| 2015-05-11 | Jeffrey B Davis Cheif Operating Officer | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2015-05-11 | Jeffrey B Davis Chief Operating Officer | Grant or award | +300,000 | $7.34 | $2.2M | 300,000 |
| 2015-05-11 | Jeffrey B Davis Chief Operating Officer | Grant or award · Stock option (right to buy) | +100,000 | $7.34 | $734K | 140,500 |
| 2014-12-24 | Jeffrey B Davis Director | Purchase | +62,500 | $4.00 | $250K | 67,858 |
| 2014-12-24 | Jeffrey B Davis Director | Other acquisition | +594,801 | $4.00 | $2.4M | 662,659 |
| 2014-12-24 | Jeffrey B Davis Director | Other acquisition | +300,852 | $4.00 | $1.2M | 963,511 |
| 2014-12-24 | Jeffrey B Davis Director | Purchase · Common Stock Purchase Warrants | +62,500 | $0.01 | $625 | 62,500 |
| 2014-12-24 | Jeffrey B Davis Director | Conversion · Series A Cumulative Convertible Preferred Stock | −237.92 | $4.00 | $952 | 0 |
| 2014-03-07 | Jeffrey B Davis CEO | Grant or award · Stock option (right to buy) | +500,000 | $0.37 | $185K | 525,000 |
| 2014-03-07 | Jeffrey B Davis CEO | Grant or award · Stock option (right to buy) | +1,500,000 | $0.37 | $555K | 2,025,000 |
| 2009-02-04 | Jeffrey B Davis Chief Executive Officer | Other acquisition | +5,950 | $3.00 | $18K | 173,250 |
| 2009-02-04 | Jeffrey B Davis Chief Executive Officer | Other acquisition | +24,897 | $2.75 | $68K | 173,250 |
| 2009-02-04 | Jeffrey B Davis Chief Executive Officer | Other acquisition | +74,709 | $0.96 | $72K | 173,250 |
Page 1 of 2 · 37 trades